RNS Number : 0951H
Surgical Innovations Group PLC
11 March 2015

Surgical Innovations Group plc

(the "Company")




The Company has previously announced that it would report a significant loss for the year ended 31 December 2014 due to a number of factors.


In connection with the preparation and audit of the annual accounts, the Board is in the process of its annual impairment review of the Company's intangible assets, which are primarily the capitalised costs of product development.  The review is not yet finalised and the results agreed with the auditors, however the Board expects that there will be an additional, substantial non-cash impairment of the intangible assets, which will impact on the results for the year.


In addition, the Board expects that the results will include a significant, non-cash write down in the carrying value of inventory.


Notwithstanding these issues, the Directors are satisfied with the progress made in restructuring the Company since the refinancing announced on 18 November 2014.  In particular, the cash position is ahead of forecast.


A further update will be provided in the announcement of the final results.





For further information please visit www.sigroupplc.com or contact:




Doug Liversidge, CBE

Non-Executive Chairman

Surgical Innovations Group Plc

Tel: 07798 892918



Tim Feather/Liam Gribben

Nominated Adviser and Broker

WH Ireland Limited

Tel: 0113 394 6600



This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings